Ludwigshafen, Germany

Matthias Kloor

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Biography of Inventor Matthias Kloor

Introduction: Matthias Kloor is a prominent inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of cancer research, particularly in the development of innovative vaccines.

Latest Patents: Matthias Kloor holds six patents, with his latest inventions focusing on MSI-specific frameshift peptides (FSP) for the prevention and treatment of cancer. These vaccines are characterized by microsatellite instability (MSI) and are designed to generate humoral and cellular responses against tumor cells. They are particularly useful for the prevention and treatment of colorectal cancer, endometrial cancer, gastric cancer, and small bowel cancer.

Career Highlights: Throughout his career, Matthias Kloor has worked at prestigious institutions, including Ruprecht-Karls-Universität Heidelberg. His research has been pivotal in advancing the understanding and treatment of cancer.

Collaborations: Matthias has collaborated with notable colleagues such as Miriam Reuschenbach and Magnus Von Knebel-Doeberitz. These partnerships have enhanced the impact of his research and innovations in the medical field.

Conclusion: Matthias Kloor's work exemplifies the vital role of inventors in the fight against cancer. His innovative approaches and dedication to research continue to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…